Email us at info@fresh-rx.com and a team member will reply quickly.
- Manufactured in the USA
- Batch Produced, Batch Tested
- Fast and Discreet Shipping
- Affordable Pricing
- 24/7 Support
Price range: $59.50 through $238.00
Tirzepatide is a groundbreaking dual GLP-1 and GIP receptor agonist that simultaneously activates both incretin pathways to deliver a synergistic and superior metabolic response. It enhances insulin secretion, suppresses glucagon release, reduces appetite, and drives greater fat mass loss than single-agonist peptides consistently outperforming Semaglutide in head-to-head research comparisons for both weight loss and glycemic control. With additional benefits for pancreatic beta cell preservation and cardiovascular risk reduction, Tirzepatide is one of the most versatile and high-value compounds available for metabolic and endocrine research today.
Tirzepatide (10MG) is an innovative dual incretin receptor agonist that simultaneously targets both GLP-1 and GIP receptors, producing a synergistic metabolic effect that surpasses the efficacy of single-agonist compounds. By activating both receptor pathways, Tirzepatide enhances insulin secretion, suppresses glucagon release, reduces appetite, and promotes greater fat mass loss compared to GLP-1 agonists alone. Research data consistently shows Tirzepatide achieving superior weight loss percentages and glycemic improvements over Semaglutide in head-to-head study comparisons. Its favorable impact on pancreatic beta cell preservation, cardiovascular risk markers, and overall metabolic rate makes it a highly versatile and valuable compound for researchers investigating Type 2 Diabetes, obesity, and related cardiometabolic conditions.
| Select MG | 5mg, 10mg, 20mg, 30mg, 60mg |
|---|
Reviews
There are no reviews yet.